Reuters Health Stories
Subjective cognitive impairment associated with hippocampal volume loss
NEW YORK (Reuters Health) - Elderly individuals who believe their cognitive performance has declined have lower hippocampal volumes than other elderly individuals, even when there is no objective evidence of cognitive impairment, according to a report in the October 7th issue of Neurology.
10/10/2008 5:12:59 PM
H. pylori-induced peptic ulcers linked with lower regulatory T cell responses
NEW YORK (Reuters Health) - Most people infected with Helicobacter pylori are asymptomatic, and a recent study by U.K.-based researchers suggests that in these individuals, the bacterium induces a regulatory T cell response that contributes to "a peaceful coexistence" with its human host. Peptic ulcer disease, on the other hand, seems to result when this regulatory response is inadequate. The study was published in the October issue of Gut.
10/10/2008 5:07:59 PM
High body mass index increases the risk of miscarriage
NEW YORK (Reuters Health) - Obesity appears to increase the risk of miscarriage, according to a meta-analysis published in the September issue of Fertility and Sterility.
10/10/2008 4:19:29 PM
Endoscopic surgery for early breast cancer may improve aesthetic results
NEW YORK (Reuters Health) - As a treatment for early breast cancer, endoscopic-assisted skin-sparing mastectomy (SSM) combined with sentinel node biopsy and immediate breast reconstruction with mammary prosthesis may improve aesthetic results without compromising oncologic control, new research suggests.
10/10/2008 4:12:29 PM
Adding cytarabine to clofarabine induction improves response rate in AML
NEW YORK (Reuters Health) - Clofarabine plus low-dose cytarabine achieves better response rates than clofarabine alone when used as front-line therapy for older patients with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS), according to a report in the September 1st issue of the journal Blood.
10/10/2008 4:04:59 PM
NSCLC in never-smokers a separate disease from NSCLC in smokers
NEW YORK (Reuters Health) - Japanese investigators say that survival rates are better for non-small cell lung cancer (NSCLC) patients who were never-smokers than in NSCLC patients with a history of smoking. Other disease characteristics are different as well between the two populations.
10/10/2008 3:59:59 PM
Triple RAAS blockade may slow progression of kidney disease
NEW YORK (Reuters Health) - Blockade of the renin-angiotensin-aldosterone system (RAAS) with three distinct treatment approaches appears to slow progression of chronic kidney disease, according to a report from Poland. It is published in the September issue of the American Journal of Kidney Diseases.
10/10/2008 3:50:59 PM
Iceland's Decode expects to stay on Nasdaq
LONDON (Reuters) - Iceland's Decode Genetics is working on refinancing and the biotech company does not expect to be delisted from the Nasdaq stock exchange for its financial woes, its chief executive said on Friday.
10/10/2008 3:00:29 PM
Guideline tackles higher mortality among hypertensive patients with diabetes
NEW YORK (Reuters Health) - Physicians need to aggressively treat high blood pressure as soon as it develops in patients with diabetes if they are to effectively lower the 7-fold higher mortality rate observed in patients with both conditions, according to a presentation today at a press conference sponsored by the American Society of Hypertension.
10/10/2008 2:32:58 PM
Risk of MI doubled in patients with rheumatoid arthritis
NEW YORK (Reuters Health) - Patients with rheumatoid arthritis (RA) are twice as likely to experience a myocardial infarction (MI) over a 3-year period compared with patients with noninflammatory rheumatic disorders, according to data from the Wichita, Kansas-based National Data Bank for Rheumatic Diseases.
10/10/2008 2:25:58 PM
Elective coronary angioplasty without anticoagulation may be safe in low-risk cases
NEW YORK (Reuters Health) - Elective percutaneous coronary intervention (PCI) involving uncomplicated lesions can be safely performed with dual antiplatelet therapy only, that is, without systemic anticoagulation, according to a double-blind, randomized, prospective study by Italian researchers published in the October 14 issue of the Journal of the American College of Cardiology.
10/10/2008 2:06:58 PM
Fewer hospital days for daily home hemodialysis patients
NEW YORK (Reuters Health) - The number of hospital days is lower for daily home hemodialysis patients than for peritoneal dialysis (PD) patients, according to a report in the October American Journal of Kidney Diseases.
10/10/2008 1:51:58 PM
Handheld echo offers rapid assessment of volume status in heart failure
NEW YORK (Reuters Health) - In patients with heart failure, clinical volume status can be rapidly and accurately determined by a non-expert at the bedside using a handheld Doppler echocardiography device and a simplified algorithm, a study indicates.
10/10/2008 1:49:28 PM
Doctors, investors get latest data on heart devices
CHICAGO (Reuters) - After years of controversy and concern over the safety and overuse of drug-coated heart stents, physicians and investors attending a cardiology meeting next week will get a clearer look at how these devices are used.
10/10/2008 1:00:36 PM
Genmab says gets $5.6 mln milestone payment from Glaxo
COPENHAGEN (Reuters) - Danish biotech firm Genmab said on Friday it received a $5.6 million milestone payment from partner GlaxoSmithKline for treating the first patient in a phase I study for its drug HuMax-CD20.
10/10/2008 1:00:28 PM
Wockhardt in licensing pact with UK firm
MUMBAI (Reuters) - Drug firm Wockhardt Ltd said on Friday it has signed an in-licensing deal with Sinclair Pharma Plc of UK to market a range of dermatology and dental products.
10/10/2008 11:00:44 AM
Drug firms agree to invest more in AIDS research: UN
UNITED NATIONS (Reuters) - U.N. Secretary-General Ban Ki-moon said on Thursday that major pharmaceutical firms promised to invest more on researching treatments for the AIDS virus and diagnostic procedures for poorer regions.
10/10/2008 11:00:35 AM
Japan's Mediceo buy Alfresa in $2 bln stock deal
TOKYO (Reuters) - Japan's top drug wholesaler Mediceo Paltac Holdings will take over No. 2 Alfresa Holdings in a $2 billion stock deal to better cope with falling prices and tough competition.
10/10/2008 11:00:27 AM
Innogenetics sees about 9.7 mln euros charges in Q3
BRUSSELS (Reuters) - Belgian biotech company Innogenetics said on Friday that it expects to record about 9.7 million euros ($13.3 million) in non-recurring charges in the third quarter of 2008.
10/10/2008 10:00:27 AM
Nobel Biocare plunges to 5-yr low after warning
ZURICH (Reuters) - Nobel Biocare shares lost over one third of their value and slumped to a five-year low on Friday, renewing takeover speculation, after the world's No.1 dental implant maker issued another profit warning.
10/10/2008 9:00:52 AM
LOOKING FOR EXPERT ADVICE?
|
 |
|
Experts here are available to answer all your questions!
